Validación argentino-chilena de la versión en espanol ˜ del test Addenbrooke’s Cognitive Examination III para el diagnóstico de demencia

Date

2017

Type:

Artículo

item.page.extent

7

item.page.accessRights

item.contributor.advisor

ORCID:

Journal Title

Journal ISSN

Volume Title

Publisher

Sociedad Española de Neurología

item.page.isbn

item.page.issn

item.page.issne

item.page.doiurl

item.page.other

item.page.references

Abstract

BACKGROUND: The Addenbrooke's Cognitive Examination III (ACE-III), an adaptation of the ACE cognitive screening test, has been demonstrated to have high sensitivity and specificity in detecting cognitive impairment in patients with dementia and other neurological and psychiatric disorders. Although the Spanish-language version of the ACE-III has already been validated in Spain, it is yet to be validated in Latin America. The aim of this study was to validate the ACE-III test in an Argentinean and Chilean population. METHODS: ACE-III was administered to 70 patients with Alzheimer disease, 31 patients with behavioural variant frontotemporal dementia, and a control group of 139 healthy volunteers. Participants were recruited at centres in both countries. RESULTS: The Spanish-language version of ACE-III was found to have good internal consistency (Cronbach's alpha=0.87). We found significant differences in total ACE-III scores between patients with Alzheimer disease and controls (p< .05) and between patients with Alzheimer disease and bvFTD (p< .05). With a cut-off point of 86, 98.6% of AD patients, 83.9% of behavioural variant frontotemporal dementia patients, and 84.2% of controls were correctly classified. CONCLUSIONS: This study shows that the Spanish-language version of ACE-III continues to be an effective tool for detecting cognitive dysfunction in patients with dementia.

Description

item.page.coverage.spatial

item.page.sponsorship

Citation

Neurologia. 2017 Aug 30. pii: S0213-4853(17)30250-5

Keywords

ACE-III, Alzheimer disease, Cognitive impairment, Dementia, Frontotemporal dementia, Screening

item.page.dc.rights

item.page.dc.rights.url